Literature DB >> 2391507

Hepatitis B virus transcripts and surface antigen in human peripheral blood lymphocytes.

A Lobbiani1, F Lalatta, F Lugo, G Colucci.   

Abstract

The presence of hepatitis B virus (HBV) genome, transcripts, and antigens (HBsAg, HBcAg, HBeAg) was examined in peripheral blood lymphocytes (PBL) from 12 patients with HBsAg-positive (B) chronic active hepatitis (CAH) and 8 normal donors by Southern and Northern blot techniques and enzyme-linked immunoassays (ELISA). HBV DNA was detected in 5 patients with B-CAH as extrachromosomal, full-length monomers of 3.2 kb. In 3 of these patients Northern blot analysis revealed the presence of the 3.6-3.8 kb RNA species, which were accompanied in one case by the HBsAg-specific 2.4 kb transcript. An ELISA performed on cell lysate obtained from this patient showed low but detectable amounts of HBsAg as compared to control PBL incubated with up to 50 micrograms/ml of the viral antigen. Serum HBV DNA was found in 3 patients with B-CAH, whereas all individuals positive for cellular HBV DNA had circulating HBeAg. These data indicate that lymphocytes from some patients with hepatitis B can harbor a transcriptionally and translationally active HBV genome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391507     DOI: 10.1002/jmv.1890310304

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Hepatitis B virus differentially suppresses myelopoiesis and displays tropism for immature hematopoietic cells.

Authors:  G K Sing; S Prior; A Fernan; G Cooksley
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

2.  Detection of hepatitis B virus DNA and determination of surface antigen expression in peripheral blood mononuclear cells from patients with AIDS.

Authors:  C Malavé Lara; M T Gorriño; C Campelo; P Lardelli; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

3.  Hepatitis B virus persistence after recovery from acute viral hepatitis.

Authors:  T I Michalak; C Pasquinelli; S Guilhot; F V Chisari
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

4.  Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).

Authors:  Yongkui Li; Jiajia Xie; Xiupeng Xu; Li Liu; Yushun Wan; Yingle Liu; Chengliang Zhu; Ying Zhu
Journal:  J Biol Chem       Date:  2013-05-31       Impact factor: 5.157

Review 5.  Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA.

Authors:  Ya-Yun Liu; Xue-Song Liang
Journal:  World J Hepatol       Date:  2018-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.